FR2381526A1 - Nouvelles combinaisons medicamenteuses et procede pour leur fabrication - Google Patents

Nouvelles combinaisons medicamenteuses et procede pour leur fabrication

Info

Publication number
FR2381526A1
FR2381526A1 FR7805382A FR7805382A FR2381526A1 FR 2381526 A1 FR2381526 A1 FR 2381526A1 FR 7805382 A FR7805382 A FR 7805382A FR 7805382 A FR7805382 A FR 7805382A FR 2381526 A1 FR2381526 A1 FR 2381526A1
Authority
FR
France
Prior art keywords
composition
manufacture
view
new drug
drug combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7805382A
Other languages
English (en)
Other versions
FR2381526B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of FR2381526A1 publication Critical patent/FR2381526A1/fr
Application granted granted Critical
Publication of FR2381526B1 publication Critical patent/FR2381526B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention a pour objet une composition antiphlogistique à base d'anti-inflammatoire non stéroïdique. Cette composition contient en tant que constituant actif, une substance ani-inflammatoire non stéroïdique quelconque ou un de ses sels compatible du point de vue physiologique et de la 5,11-dihydro-11 Ø(4-méthyl-1-pipérazinyl)acétylõ-6H-pyrido Ø2,3bõ Ø1,4õ benzodiazépine-6-one/pirenzépine ou un de ses sels, sans inconvénient du point de vue physiologique, avec un acide minéral ou organique, et éventuellement encore d'autres substances connues actives du point de vue pharmacologique et/ou des excipients et/ou adjuvants courants. Une telle composition ne présente pas l'effet ulcérogène des antiphlogistiques non stéroïdiques tout en gardant intactes leurs propriétés utiles.
FR7805382A 1977-02-26 1978-02-24 Nouvelles combinaisons medicamenteuses et procede pour leur fabrication Granted FR2381526A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772708520 DE2708520A1 (de) 1977-02-26 1977-02-26 Neue arzneimittelkombinationen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2381526A1 true FR2381526A1 (fr) 1978-09-22
FR2381526B1 FR2381526B1 (fr) 1980-01-18

Family

ID=6002319

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7805382A Granted FR2381526A1 (fr) 1977-02-26 1978-02-24 Nouvelles combinaisons medicamenteuses et procede pour leur fabrication

Country Status (17)

Country Link
US (3) US4154833A (fr)
JP (1) JPS53107424A (fr)
AU (1) AU519763B2 (fr)
BE (1) BE864315A (fr)
CA (1) CA1107199A (fr)
CH (1) CH642548A5 (fr)
DE (1) DE2708520A1 (fr)
FR (1) FR2381526A1 (fr)
GB (1) GB1572779A (fr)
IE (1) IE46467B1 (fr)
IL (1) IL54129A (fr)
IT (1) IT1101769B (fr)
LU (1) LU79124A1 (fr)
NL (1) NL7802023A (fr)
NZ (1) NZ186563A (fr)
PH (2) PH15663A (fr)
ZA (1) ZA781086B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093520B1 (fr) * 1982-04-27 1986-10-15 Noristan Limited Compositions pharmaceutiques et leur préparation
US4551463A (en) * 1982-11-03 1985-11-05 Schering Corporation Composition containing 1-phenyl-1,8-naphthridin-2(1H)-ones and a non-steroidal anti-inflammatory drug
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4996232A (en) * 1985-10-25 1991-02-26 Cadbury Schweppes Proprietary Limited Reducing bacterial content in water
US5211957A (en) * 1988-03-25 1993-05-18 Ciba-Geigy Corporation Solid rapidly disintegrating dosage form
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5179090A (en) * 1989-09-11 1993-01-12 Klaus Rudolf Condensed diazepinones and medicaments containing these compounds
JPH03242499A (ja) * 1990-02-19 1991-10-29 Mitsubishi Electric Corp 多翼送風機の羽根車

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790086A (fr) * 1971-10-15 1973-04-13 Thomae Gmbh Dr K Le 4-(4-biphenylyl)-1-butanol

Also Published As

Publication number Publication date
ZA781086B (en) 1979-10-31
IE46467B1 (en) 1983-06-15
US4292319A (en) 1981-09-29
JPS53107424A (en) 1978-09-19
FR2381526B1 (fr) 1980-01-18
GB1572779A (en) 1980-08-06
DE2708520A1 (de) 1978-08-31
IT1101769B (it) 1985-10-07
LU79124A1 (de) 1979-05-25
NL7802023A (nl) 1978-08-29
AU519763B2 (en) 1981-12-24
PH17554A (en) 1984-09-20
DE2708520C2 (fr) 1988-03-17
IT7848149A0 (it) 1978-02-22
US4154833A (en) 1979-05-15
IL54129A0 (en) 1978-04-30
CA1107199A (fr) 1981-08-18
BE864315A (fr) 1978-08-24
AU3360178A (en) 1979-08-30
CH642548A5 (de) 1984-04-30
NZ186563A (en) 1981-07-13
IE780403L (en) 1978-08-26
US4256747A (en) 1981-03-17
IL54129A (en) 1981-01-30
JPS6141896B2 (fr) 1986-09-18
PH15663A (en) 1983-03-11

Similar Documents

Publication Publication Date Title
KR950016783A (ko) 조절 방출용 약학 조성물
FR2381526A1 (fr) Nouvelles combinaisons medicamenteuses et procede pour leur fabrication
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
FR2627696B1 (fr) Nouvelle forme galenique du fenofibrate
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
BR9611015A (pt) Composto, composição farmacêutica e processo para o tratamento de uma doença inflamatória suscetìvel ao tratamento com um agente não-tóxico anti-inflamatório não-esteróide, sal farmaceuticamente aceitável, utilização de um composto
OA03150A (fr) Procédé d'augmentation de la teneur en sucre de la canne à sucre.
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
FR2421620A1 (fr) Composition microbicide a base de 4,5-dichloro-1,2-dithiol-3-one et son application
FR2541115B1 (fr) Medicament renfermant un peptide en tant que principe actif pour le traitement des affections ulcereuses
FR2422657A1 (fr) 2-(2-thenoylthio)-propionylglycine, procede pour sa preparation et compositions pharmaceutiques la contenant
ES520813A0 (es) Procedimiento para la obtencion del ester del acido 2-(2,6-diclorofenil)amino bencenoacetico con acido glicolico.
ES2170318T3 (es) Derivados de 10,13,15-trioxatriciclo(9.2.1.1.9.6)-pentadecanona, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
KR930702965A (ko) 생체이용성이 개선된 프로부콜 함유 제약 조성물
FR2377804A1 (fr) Compositions analgesiques et anti-inflammatoires comprenant des derives de chromone
BE817987A (fr) Masse pour une electrode emissive refractaire ainsi que procedepour la fabrication d'une telle masse
FR2395272A1 (fr) Nouveaux medicaments derives de l'acide amidinopenicillanique
FR2368959A1 (fr) Compositions contenant des derives de l'acide guanidinoalcanoique, utilisables comme medicament
SE7910554L (sv) Disulfidforeningar
ES485168A0 (es) Un procedimiento para la preparacion de una composicion far-maceutica util para el tratamiento de la hipercolesteremia.
ES494303A0 (es) Un procedimiento para la preparacion de precursores de alil sulfoxidos inhibidores de enzimas.
FR2404010A1 (fr) Nouveaux derives de pyrimido-(2,1-a)isoquinoleine, leur procede de production et composition pharmaceutique les contenant
OA07540A (fr) Nouveaux dérivés de l'acide cyclopropane carboxylique, leur préparation, leur application à la lutte contre les parasites et les compositions les renfermant.
FR2401132A1 (fr) Nouveaux derives de triphenylbutene-1, leur procede de production et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse